Search

Your search keyword '"Kafaar, Zuhayr"' showing total 25 results
Start Over Author "Kafaar, Zuhayr"
25 results on '"Kafaar, Zuhayr"'

3. Orientations to Academic Development: Lessons from a Collaborative Study at a Research-Led University

Author

Leibowitz, Brenda, Cilliers, Francois, du Plessis, Jacob, Kafaar, Zuhayr, Van der Merwe, Antoinette, Viljoen, Shaun, and Young, Gert

Abstract

This study reports on a collaborative teaching enhancement project at a research-led university, within the context of a focus on the first-year experience. It demonstrates the kind of influence which a combination of managerial and collegial approaches can have on the collaboration. It illustrates the importance of working with a conscious understanding of the academic development orientations underpinning an educational change initiative. In the study, academic developers teamed up with lecturers from eight departments to embark on change endeavours to enhance teaching and learning in the lecturers' immediate settings. The adoption of an action research-oriented, interdisciplinary and collaborative approach to professional development was found to be appropriate at a research-led institution. Contextual and cultural factors inherent to the disciplines, departments and institution were shown to have an impact upon the involvement of participants in the project. (Contains 2 tables and 1 note.)

Published
2011
Full Text
View/download PDF

4. Scaling Up Child and Adolescent Mental Health Services in South Africa: Human Resource Requirements and Costs

Author

Lund, Crick, Boyce, Gerard, Flisher, Alan J., Kafaar, Zuhayr, and Dawes, Andrew

Abstract

Background: Children and adolescents with mental health problems have poor service cover in low- and middle-income countries. Little is known about the resources that would be required to provide child and adolescent mental health services (CAMHS) in these countries. The purpose of this study was to calculate the human resources and associated costs required to scale up CAMHS in South Africa. Methods: A spreadsheet model was developed to calculate mental health service resources, based on an estimation of the need for services in a given population. The model can be adapted to specific settings by adjusting population size, age distribution, prevalence, comorbidity, levels of coverage, service utilisation rates, workloads, length of consultations and staff profile. Steps in the modelling include population identification; estimates of prevalence, service utilisation and staffing; and costing. Results: Using a nominal total population of 100,000 (of which 43,170 would be children and adolescents under 20 years of age), the following full-time equivalent staff are required at minimum coverage level: 5.8 in PHC facilities, 0.6 in general hospital outpatient departments (OPDs), 0.1 in general hospital inpatient facilities, 1.1 in specialist CAMHS OPDs, 0.6 in specialist CAMHS inpatient facilities, 0.5 in specialist CAMHS day services, and 0.8 in regional CAMHS teams. This translates into roughly $21.50 and $5.99 per child or adolescent per annum nationally for the full coverage and minimum coverage scenarios respectively. When comparing the results of this model with current realities in South Africa, there remains a substantial shortfall in existing levels of CAMHS provision. Conclusions: The model can be used as an advocacy tool to engage with planners and policy makers on a rational basis. It can also be adapted for use in other countries, and is intended to support wider calls for a global scaling up of mental health services.

Published
2009
Full Text
View/download PDF

6. Social and behavioral aspects of child and adolescent participation in HIV vaccine trials

Author

Swartz, Leslie, Kagee, Ashraf, Kafaar, Zuhayr, Smit, Joalida, Bhana, Arvin, Gray, Glenda, Lesch, Anthea, Lindegger, Graham, Milford, Cecilia, Richter, Linda, Seedat, Soraya, Skhosana, Nokuthula, and Stein, Dan J.

Subjects
Human experimentation in medicine -- Management -- Social aspects -- Research -- Health aspects, Children -- Behavior -- Health aspects, Teenagers -- Behavior -- Health aspects, Youth -- Behavior -- Health aspects, Self-experimentation in medicine -- Management -- Social aspects -- Research -- Health aspects, Risk-taking (Psychology) -- Research -- Social aspects -- Health aspects, AIDS vaccines -- Product development -- Research, Health, Company business management, Management, Social aspects, Research, Behavior, Health aspects, Product development
Abstract

Recent data indicate that the worldwide rate of HIV infection in adolescents is steadily increasing. Internationally, more than 7000 youths between 15 and 24 years of age are infected with [...]

Published
2005

10. The trouble with difference: Challenging and reproducing inequality in a biomedical HIV research community engagement process.

Author

de Wet, Anneliese, Swartz, Leslie, Kagee, Ashraf, Lesch, Anthea, Kafaar, Zuhayr, Hassan, Neil R., Robbertze, Danté, and Newman, Peter A.

Subjects
HIV prevention, COMMUNITIES, SEXUAL health, MEDICAL research, PRACTICAL politics, MEDICAL care for teenagers, REPRODUCTIVE health, CULTURAL awareness
Abstract

Community engagement in biomedical trials is to ensure ethical conduct in research, yet it has been criticised regarding power and exploitation of vulnerable communities where trials take place. This makes community engagement processes complex. We report on one example of how the global politics of biomedical research and local issues of contemporary politics and identities intertwine in a community engagement process. These issues emerged during observations in staff training at a biomedical HIV prevention trial centre in South Africa from September to November 2015. Within the practices of the training sessions, the sessions had an unintended and not explicitly discussed purpose, termed the hidden project of creating a safe space for participants to discuss issues of difference. Examples are culture and greeting practices, culture and respect and the politics of language. Creating a space during training sessions where issues of power may be discussed is a prime example of community engagement. Engagement includes creating the space to discuss differences and collaborative bases. Processes of meaningful community stakeholder engagement, as illustrated by the training sessions, may contribute to combination prevention of HIV by promoting the integration of behavioural, sociocultural and biomedical efforts, and by a more developed understanding of power. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

11. Caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials.

Author

Kagee, Ashraf, De Wet, Anneliese, Kafaar, Zuhayr, Lesch, Anthea, Swartz, Leslie, and Newman, Peter A

Subjects
AIDS vaccines, CLINICAL health psychology, CLINICAL trials, CONSENSUS (Social sciences), HEALTH education, MEDICAL research, PATIENT participation, SYSTEMATIC reviews, DISEASE incidence
Abstract

HIV vaccine efficacy trials require the enrolment of large numbers of HIV-negative individuals and thus it is necessary to engage with communities where HIV incidence is high. We identify some of the caveats and pitfalls associated with researching community engagement in the context of HIV vaccine trials. These are as follows: the lack of consensus of what community engagement is and how it is practiced, the sometimes paradoxical role of community advisory boards as community representatives and challenges associated with information dissemination in communities. We identify a set of considerations for community engagement practitioners, trial investigators and social scientists when conducting community engagement. [ABSTRACT FROM AUTHOR]

Published
2020
Full Text
View/download PDF

23. Participation in HIV Vaccine Trials.

Author

Lesch, Anthea, Kafaar, Zuhayr, and Kagee, Ashraf

Abstract

South Africa΄s AIDS epidemic has been classified as amongst the worst in the world and shows no evidence of declining (UNAIDS, 2006). While existing behaviour change initiatives to reduce the incidence of HIV have been proven efficacious in research settings, they have had limited success when implemented in real-world settings. In the HIV prevention arena, it has been widely argued that a safe and affordable HIV preventive vaccine will offer the best hope of halting the spread of HIV (Esparza and Bhamarapravati, 2000; Kahn, 2005). However, the vaccine development process is a lengthy one and has historically been beset with many challenges and setbacks. The complexity of the HI-virus means that a longer timeline and innovative approaches will be required to achieve the ultimate goal of the HIV vaccine enterprise, i.e., an effective HIV vaccine. Efforts to develop an HIV vaccine have been underway for more than a decade and while researchers have managed to generate evidence for the feasibility of candidate HIV vaccines in animal models, they have not yet managed to illustrate that it provides the same benefit in humans. [ABSTRACT FROM AUTHOR]

Published
2010
Full Text
View/download PDF

24. Social and behavioral science in HIV vaccine trials: a gap assessment of the literature.

Author

Chuen-Yen Lau, Stansbury, James P., Gust, Deborah A., and Kafaar, Zuhayr

Subjects
AIDS vaccination research, CLINICAL trials, SOCIAL sciences, PSYCHOLOGY, AIDS vaccines, HEALTH policy
Abstract

Social and behavioral science research is integral to the conduct of HIV vaccine trials, especially because the vaccine targets an infection laden with sensitive human issues. Although social and behavioral sciences have played a larger role in HIV vaccine clinical trials than other vaccine clinical trials to date, this role should be expanded. Fortunately, related publications, conference coverage and research proposals are on the rise; community engagement is receiving more attention during the earlier stages of product development; and collaboration between HIV vaccine scientists and social and behavioral scientists is being fostered. Greater attention to social and behavioral science issues could not only facilitate accrual, but also improve research efficiency and relevance. In this review, gaps in the literature on social and behavioral science issues in HIV vaccine clinical research, including barriers and facilitators to trial participation, enhancing feasibility of trial success, health systems, policy and monitoring social and behavioral issues, are identified and directions are suggested for filling those gaps. Development of a safe, efficacious and acceptable HIV vaccine will be nurtured by addressing the gaps through interdisciplinary collaborations. [ABSTRACT FROM AUTHOR]

Published
2009
Full Text
View/download PDF

25. Afri-Can Forum 2

Author

Mukudu, Hillary, Martinson, Neil, Sartorius, Benn, Coetzee, Jenny, Dietrich, Janan, Mokgatswana, Kgaugelo, Jewkes, Rachel, Gray, Glenda E, Dugas, Marylène, Béhanzin, Luc, Guédou, Fernand A, Gagnon, Marie-Pierre, Alary, Michel, Rutakumwa, Rwamahe, Mbonye, Martin, Kiwanuka, Thadeus, Nakamanya, Sarah, Muhumuza, Richard, Nalukenge, Winfred, Seeley, Janet, Atujuna, Millicent, Wallace, Melissa, Brown, Ben, Bekker, Linda G, Newman, Peter A, Harryparsad, Rushil, Olivier, Abraham J, Jaspan, Heather B, Wilson, Douglas, Mkhize, Nonhlanhla, Morris, Lynn, Cianci, Gianguido, Dinh, Minh, Hope, Thomas, Passmore, Jo-Ann S, Gray, Clive M, Henrick, Bethany M, Yao, Xiao-Dan, Rosenthal, Kenneth L, Drannik, Anna G, Abimiku, Alash’le, Chanzu, Nadia, Mwanda, Walter, Oyugi, Julius, Anzala, Omu, Mbow, Moustapha, Jallow, Sabelle, Thiam, Moussa, Davis, Alberta, Diouf, Assane, Ndour, Cheikh T, Seydi, Moussa, Dieye, Tandakha N, Mboup, Souleymane, Goodier, Martin, Rilley, Eleanor, Jaye, Assan, Omange, RW., Lester, Richard T, Kimani, Joshua, Ball, T. B, Plummer, Francis A, Geraldo, Nassirou, Mastétsé, Ella G, Sossa, Jerôme C, Zannou, Marcel D, Osawe, Sophia, Okpokoro, Evaezi, Okolo, Felicia, Umaru, Stephen, Abimiku, Rebecca, Audu, Sam, Datong, Pam, Nyange, Jacquelyn, Olenja, Joyce, Mutua, Gaudensia, Jaoko, Walter, Omosa-Manyonyi, Gloria, Farah, Bashir, Khaniri, Maureen, Cockcroft, Anne, Tonkin, Kendra, Girish, Indu, Mhati, Puna, Cunningham, Ashley, Andersson, Neil, Indangasi, Jackton, Diphoko, Thabo, Gaseitsiwe, Simani, Maiswe, Victoria, Iketleng, Thato, Maruapula, Dorcas, Bedi, Keabetswe, Moyo, Sikhulile, Musonda, Rosemary, Wainberg, Mark, Makhema, Joseph, Novitsky, Vladimir, Marlink, Richard, Essex, Max, Okoboi, Stephen, Ssali, Livingstone, Kalibala, Sam, Birungi, Josephine, Egessa, Aggrey, Wangisi, Jonathan, Okullu, Lyavala J, Bakanda, Celestin, Obare, Francis, Boer, I. M S, Semvua, Hadija H, Van Den Boogaard, Jossy, Kiwango, Krisanta W, Ngowi, Kennedy M, Nieuwkerk, Pythia T, Aarnoutse, Rob E, Kiwelu, Ireen, Muro, Eva, Kibiki, Gibson S, Datiri, Ruth, Choji, Grace, Audu, Samuel, Fomsgaard, A., Karlsson, I., Jensen, K. J, Jensen, S. S, Leo-Hansen, C., Jespersen, S., Da Silva Té, D., Rodrigues, C. M, Da Silva, Z. J, Janitzek, C. M, Gerstoft, J., Kronborg, G., Daitiri, Ruth, Emily, Nyariki, Joyce, Olenja, Robert, Lorway R, Anzala, Anzala, Viljoen, Katie, Wendoh, Jerome, Kidzeru, Elvis, Karaoz, Ulas, Brodie, Eoin, Botha, Gerrit, Mulder, Nicola, Gray, Clive, Cameron, William, Stintzi, Alain, Jaspan, Heather, Levett, Paul N, Alexander, David, Gulzar, Naveed, Grewal, Prabvir S, Poon, Art F Y, Brumme, Zabrina, Harrigan, P. R, Brooks, James I, Sandstrom, Paul A, Calvez, Stryker, Sanche, Stephen E, Scott, Jamie K, Swartz, Leslie, Kagee, Ashraf, Lesch, Anthea, Kafaar, Zuhayr, De Wet, Anneliese, Smith, Tricia, Cotton, Laura, Hornschuh, Stefanie, Van Der Watt, Martin, Miller, Cari L, Gray, Glenda, Smit, Jenni, Jaggernath, Manjeetha, Ndung’u, Thumbi, Brockman, Mark, Kaida, Angela, Akolo, Maureen, Gelmon, Larry, Chitwa, Michael, Osero, Justus, Marokoane, Nobantu, Kgakole, Leagajang, Maswabi, Boikhutso, Mpofu, Neo, Ansari, Umaira, Nakinobe, Elizabeth, Miiro, George M, Zalwango, Flavia, Nakiyingi-Miiro, Jessica, Kaleebu, Potiano, Semwanga, John R, Nyanzi, Emily, Musoke, Saidat N, Miiro, George, Mbidde, Edward K, Lutalo, Tom, Kaleebu, Pontiano, Handema, Ray, Chianzu, Graham P, Diagne-Gueye, Diabou, Ndiaye, Mame K, Ndiaye, Birahim P, Traore, Ibrahima, Dia, Mamadou C, Thomas, Gilleh, Tour-Kane, Coumba, Mpendo, Juliet, Muyindike, Winnie, Kambugu, Andrew, Sebastian, Hachizovu, Ray, Handema, Mike, Chaponda, Bertin, Kabuya J, Modest, Mulenga, Janha, Omar, Amambua-Ngwa, Alfred, Nwakanma, Davis C, Jespersen, Sanne, Hønge, Bo L, Esbjörnsson, Joakim, Medina, Candida, Da Silva TÉ, David, Correira, Faustino G, Laursen, Alex L, Østergaard, Lars, Andersen, Andreas, Aaby, Peter, Erikstrup, Christian, Wejse, Christian, Dieye, Siry, Sarr, Moussa, Sy, Haby, Mbodj, Helene D, Ndiaye, Marianne, Ndiaye, Amy, Moussa, Seydi, Nyombi, Balthazar M, Shao, Elichilia R, Chilumba, Innocent B, Inyang, Bucky, Izang, Abel, Cole, Chundung, Cameron, Bill, Rosenthal, Kenneth, Seraise, Boitumelo, and Andrea-Marobela, Kerstin

Subjects
Infectious Diseases
Abstract

Table of contents A1 Introduction to the 2nd synchronicity forum of GHRI/CHVI-funded Canadian and African HIV prevention and vaccine teams O1 Voluntary medical male circumcision for prevention of heterosexual transmission of HIV in adult males in Soweto: What do indicators and incidence rate show? Hillary Mukudu, Neil Martinson, Benn Sartorius O2 Developing a peer-led community mobilization program for sex workers in Soweto: HIV risk and demographics Jenny Coetzee, Janan Dietrich, Kgaugelo Mokgatswana, Rachel Jewkes, Glenda E. Gray O3 Salient beliefs about adherence: A qualitative survey conducted as part of the demonstration study on "treatment as prevention" (TasP) and "pre-exposure prophylaxis" (PrEP) among female sex workers (FSWS) in Cotonou, Benin Marylène Dugas, Luc Béhanzin, Fernand A. Guédou, Marie-Pierre Gagnon, Michel Alary O4 Relative perception of risk as a driver of unsafe sexual practices among key populations: Cases of fisherfolk and women and their partners involved in multiple sexual partnerships in Uganda Rwamahe Rutakumwa, Martin Mbonye, Thadeus Kiwanuka, Sarah Nakamanya, Richard Muhumuza, Winfred Nalukenge, Janet Seeley O5 Exploring the acceptability of new biomedical HIV prevention technologies among MSM, adolescents and heterosexual adults in South Africa Millicent Atujuna, Melissa Wallace, Ben Brown, Linda Gail Bekker, Peter A. Newman O6 HIV-susceptible target cells in foreskins after voluntary medical male circumcision in South Africa Rushil Harryparsad, Abraham J. Olivier, Heather B. Jaspan, Douglas Wilson, Janan Dietrich, Neil Martinson, Hillary Mukudu, Nonhlanhla Mkhize, Lynn Morris, Gianguido Cianci, Minh Dinh, Thomas Hope, Jo-Ann S. Passmore, Clive M. Gray O7 HIV-1 proteins activate innate immune responses via TLR2 heterodimers Bethany M. Henrick, Xiao-Dan Yao, Kenneth L. Rosenthal, the INFANT Study Team O8 Characterization of an innate factor in human milk and mechanisms of action against HIV-1 Bethany M. Henrick, Xiao-Dan Yao, Anna G. Drannik, Alash’le Abimiku, Kenneth L. Rosenthal, the INFANT Study Team O9 Secretor status and susceptibility to HIV infections among female sex workers in Nairobi, Kenya Nadia Chanzu, Walter Mwanda, Julius Oyugi, Omu Anzala O10 Natural Killer cell recall responsiveness to Gag-HIV-1 peptides of HIV-1 exposed but uninfected subjects are associated with peripheral CXCR6+ NK cell subsets Moustapha Mbow, Sabelle Jallow, Moussa Thiam, Alberta Davis, Assane Diouf, Cheikh T. Ndour, Moussa Seydi, Tandakha N. Dieye, Souleymane Mboup, Martin Goodier, Eleanor Rilley, Assan Jaye O11 Profiles of resistance: Local innate mucosal immunity to HIV-1 in commercial sex workers Xiao-Dan Yao, RW. Omange, Bethany M. Henrick, Richard T. Lester, Joshua Kimani, T. Blake Ball, Francis A. Plummer, Kenneth L. Rosenthal O12 Early antiretroviral therapy and pre-exposure prophylaxis for HIV prevention among female sex workers in Cotonou, Benin: A demonstration project Luc Béhanzin, Fernand A. Guédou, Nassirou Geraldo, Ella Goma Mastétsé, Jerôme Charles Sossa, Marcel Djimon Zannou, Michel Alary O13 Building capacity for HIV prevention trials: Preliminary data from a Nigerian cohort of HIV exposed sero-negatives (HESN) Sophia Osawe, Evaezi Okpokoro, Felicia Okolo, Stephen Umaru, Rebecca Abimiku, Sam Audu, Pam Datong, Alash’le Abimiku O14 Equipping healthcare professionals with skills required for the conduct of clinical trials in an effort to build capacity. Lessons learned Jacquelyn Nyange, Joyce Olenja, Gaudensia Mutua, Walter Jaoko, Gloria Omosa-Manyonyi, Bashir Farah, Maureen Khaniri, Omu Anzala O15 Educational technology to support active learning for HIV researchers and planners Anne Cockcroft, Kendra Tonkin, Indu Girish, Puna Mhati, Ashley Cunningham, Neil Andersson O16 From Lake Kivu (Rwanda) and Lake Malawi (Tanzania) to the shores of Lake Victoria (Uganda): Strengthening laboratory capacity through Good Clinical Laboratory Practice training Bashir Farah, Jackton Indangasi, Walter Jaoko, Gaudensia Mutua, Maureen Khaniri, Jacquelyn Nyange, Omu Anzala O17 Rilpivirine and etravirine resistance mutations in HIV-1 subtype C infected patients on a non-nucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy in Botswana Thabo Diphoko, Simani Gaseitsiwe, Victoria Maiswe, Thato Iketleng, Dorcas Maruapula, Keabetswe Bedi, Sikhulile Moyo, Rosemary Musonda, Mark Wainberg, Joseph Makhema, Vladimir Novitsky, Richard Marlink, Max Essex O18 From home-based HIV testing to initiation of treatment: The AIDS Support Organization (TASO) Experience with Home-based HIV Counselling and Testing (HBHCT) among Adolescents in Uganda, 2005-2011 Stephen Okoboi, Livingstone Ssali, Sam Kalibala, Josephine Birungi, Aggrey Egessa, Jonathan Wangisi, Lyavala Joanne Okullu, Celestin Bakanda, Francis Obare41 O19 Feasibility study on using real time medication monitoring among HIV infected and Tuberculosis patients in Kilimanjaro, Tanzania I. Marion Sumari-de Boer, Hadija H. Semvua, Jossy van den Boogaard, Krisanta W. Kiwango, Kennedy M. Ngowi, Pythia T. Nieuwkerk, Rob E. Aarnoutse, Ireen Kiwelu, Eva Muro, Gibson S. Kibiki O20 Deaths still among sero-discordant cohort in Nigeria despite Access to treatment Ruth Datiri, Grace Choji, Sophia Osawe, Evaezi Okpokoro, Felicia Okolo, Stephen Umaru, Rebecca Abimiku, Samuel Audu, Pam Datong, Alash’le Abimiku O21 Therapeutic HIV-1 vaccine trials in Denmark and Guinea-Bissau Fomsgaard A, Karlsson I, Jensen KJ, Jensen SS, Leo-Hansen C, Jespersen S, Da Silva Té D, Rodrigues CM, da Silva ZJ, Janitzek CM, Gerstoft J, Kronborg G, the WAPHIR Group O22 Willingness to participate in a HIV vaccine Trial among HIV exposed sero-negative (HESN) persons in Jos, Nigeria Evaezi Okpokoro, Sophia Osawe, Ruth Daitiri, Grace Choji, Stephen Umaru, Felicia Okolo, Pam Datong, Alash'le Abimiku O23 Clinical research volunteers’ perceptions and experiences of screening for enrolment at KAVI-Institute of Clinical Research, Kenya Nyariki Emily, Olenja Joyce, Lorway R. Robert, Anzala Anzala O24 Gut microbiome, HIV-exposure, and vaccine responses in South African infants Katie Viljoen, Jerome Wendoh, Elvis Kidzeru, Ulas Karaoz, Eoin Brodie, Gerrit Botha, Nicola Mulder, Clive Gray, William Cameron, Alain Stintzi, Heather Jaspan, for the INFANT study team O25 Analysis of HIV pol diversity in the concentrated HIV epidemic in Saskatchewan Paul N. Levett, David Alexander, Naveed Gulzar, Prabvir S. Grewal, Art F. Y. Poon, Zabrina Brumme, P. Richard Harrigan, James I. Brooks, Paul A. Sandstrom, Stryker Calvez, Stephen E. Sanche, Jamie K. Scott P1 Evaluating a HIV vaccine research community engagement programme at two HIV prevention research centres in the Western Cape Leslie Swartz, Ashraf Kagee, Anthea Lesch, Zuhayr Kafaar, Anneliese De Wet P2 Validating HIV acquisition risk score using a cohort HIV exposed sero-negative persons in a discordant relationship in Jos, Nigeria, West Africa Evaezi Okpokoro, Sophia Osawe, Ruth Daitiri, Grace Choji, Stephen Umaru, Felicia Okolo, Pam Datong, Alash'le Abimiku P3 Bridging the gap between adults and adolescents and youth adults (AYA) – Employing a youth-centred approach to investigate HIV risk among AYA in Soweto and Durban, South Africa Janan Dietrich, Tricia Smith, Laura Cotton, Stefanie Hornschuh, Martin van der Watt, Cari L. Miller, Glenda Gray, Jenni Smit, Manjeetha Jaggernath, Thumbi Ndung’u, Mark Brockman, Angela Kaida, on behalf of the AYAZAZI study teams P4 Neighbours to sex workers: A key population that has been ignored Maureen Akolo, Joshua Kimani, Prof Larry Gelmon, Michael Chitwa, Justus Osero P5 Young women’s access to structural support programmes in a district of Botswana Anne Cockcroft, Nobantu Marokoane, Leagajang Kgakole, Boikhutso Maswabi, Neo Mpofu, Umaira Ansari, Neil Andersson P6 Voices for action from peri-urban Ugandan students, teachers and parents on HIV/STI prevention: Qualitative research results Nakinobe Elizabeth, Miiro George Mukalazi, Zalwango Flavia, Nakiyingi-Miiro Jessica, Kaleebu Potiano P7 Engaging Social Media as an education tool on the fly: The use of Facebook for HIV and Ebola prevention and awareness amongst adolescents in Uganda John Ross Semwanga, Emily Nyanzi, Saidat Namuli Musoke, Elizabeth Nakinobe, George Miiro, Edward Katongole Mbidde, Tom Lutalo, Pontiano Kaleebu P8 Circulating HIV-1 subtypes among sexual minority populations in Zambia Ray Handema, Graham P. Chianzu P9 The Development of HIV Bio-bank resource management to support clinical trial and Intervention research: WAPHIR experience Moussa Thiam, Diabou Diagne-Gueye, Mame K. Ndiaye, Moustapha Mbow, Birahim P. Ndiaye, Ibrahima Traore, Mamadou C. Dia, Gilleh Thomas, Coumba Tour-Kane, Souleymane Mboup, Assan Jaye P10 Capacity building for clinical trials as a novel approach for scaling up HIV prevention research initiatives in East Africa: achievements and challenges Emily Nyanzi, Edward Katongole Mbidde, Pontiano Kaleebu, Juliet Mpendo, Joshua Kimani, Josephine Birungi, Winnie Muyindike, Andrew Kambugu P11 Community and media perspective of research; an advocacy workshop on HIV prevention research Hachizovu Sebastian, Handema Ray, Chaponda Mike, Kabuya Jean Bertin, Mulenga Modest P12 Development of a quantitative HIV-1 and HIV-2 real time PCR (qRT-PCR) viral load assay Moussa Thiam, Omar Janha, Alberta Davis, Alfred Amambua-Ngwa, Davis C. Nwakanma, Souleymane Mboup, Assan Jaye P13 Differential effects of sex in a West African Cohort of HIV-1, HIV-2 and HIV-1/2 dual infected patients: Men are worse off Sanne Jespersen, Bo Langhoff Hønge, Joakim Esbjörnsson, Candida Medina, David Da Silva TÉ, Faustino Gomes Correira, Alex Lund Laursen, Lars Østergaard, Andreas Andersen, Peter Aaby, Christian Erikstrup, Christian Wejse, for the Bissau HIV Cohort study group P14 HIV-infected adolescents in transition from pediatric to adult HIV care in Dakar, Senegal: sample characteristics and immunological and virological profiles Siry Dieye, Moussa Sarr, Haby Sy, Helene D Mbodj, Marianne Ndiaye, Amy Ndiaye, Seydi Moussa, Assan Jaye, Souleymane Mboup100 P15 Molecular characterization of vertically transmitted HIV-1 among children born to HIV-1 seropositive mothers in Northern Tanzania Balthazar M. Nyombi, Elichilia R. Shao, Innocent B. Chilumba, Sikhulile Moyo, Simani Gaseitsiwe, Rosemary Musonda P16 Breast-fed HIV-1 exposed infants play catch up. A preliminary report Pam Datong, Bucky Inyang, Sophia Osawe, Abel Izang, Chundung Cole, Felicia Okolo, Bill Cameron, Kenneth Rosenthal, Clive Gray, Heather Jaspan, Alash’le Abimiku, the INFANT study team P17 The frequency of N348I mutation in patient failing combination antiretroviral treatment In Botswana Boitumelo Seraise, Kerstin Andrea-Marobela, Sikhulile Moyo, Rosemary Musonda, Joseph Makhema, Max Essex, Simani Gaseitsiwe

Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results